Host-targeting therapies for hepatitis C virus infection: current developments and future applications

Chronic hepatitis C virus (HCV) infection is a leading cause of chronic liver diseases and hepatocellular carcinoma (HCC) worldwide. In the past few years, anti-HCV therapies have undergone a revolution with the approval of multiple direct-acting antivirals (DAAs), which enable interferon-free treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Crouchet, Emilie, Wrensch, Florian, Schuster, Catherine, Zeisel, Mirjam B., Baumert, Thomas F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5871046/
https://www.ncbi.nlm.nih.gov/pubmed/29619090
http://dx.doi.org/10.1177/1756284818759483

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5871046/
https://www.ncbi.nlm.nih.gov/pubmed/29619090
http://dx.doi.org/10.1177/1756284818759483

Ejemplares similares